Seaport Res Ptn Forecasts Higher Earnings for TerrAscend

Key Points

• Seaport Res Ptn has upgraded TerrAscend's FY2025 earnings estimate to (\$0.10), reflecting an improvement from the previous estimate of (\$0.13).
• TerrAscend's stock has been raised from a "hold" to a "strong-buy" rating by ATB Cap Markets as of May 8th.
• For its latest quarter, TerrAscend reported earnings of (\$0.03) per share, missing the analysts' consensus estimate by (\$0.01).

TerrAscend Corp. (OTCMKTS:TSNDF - Free Report) - Equities research analysts at Seaport Res Ptn lifted their FY2025 earnings estimates for TerrAscend in a report issued on Wednesday, August 6th. Seaport Res Ptn analyst S. Randhawa now anticipates that the company will post earnings of ($0.10) per share for the year, up from their previous estimate of ($0.13). The consensus estimate for TerrAscend's current full-year earnings is ($0.14) per share. Seaport Res Ptn also issued estimates for TerrAscend's FY2026 earnings at ($0.09) EPS.

Separately, Atb Cap Markets raised shares of TerrAscend from a "hold" rating to a "strong-buy" rating in a research report on Thursday, May 8th.

TerrAscend Stock Up 1.1%

TerrAscend stock traded up $0.01 during midday trading on Monday, hitting $0.90. 690,718 shares of the stock were exchanged, compared to its average volume of 649,075. TerrAscend has a 52-week low of $0.23 and a 52-week high of $1.75. The stock has a market capitalization of $275.38 million, a price-to-earnings ratio of -2.19 and a beta of 1.39. The business's 50-day moving average price is $0.37 and its 200-day moving average price is $0.41. The company has a quick ratio of 1.07, a current ratio of 1.45 and a debt-to-equity ratio of 1.94.

TerrAscend (OTCMKTS:TSNDF - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.01). TerrAscend had a negative return on equity of 23.19% and a negative net margin of 40.86%. The firm had revenue of $65.01 million for the quarter, compared to analysts' expectations of $64.87 million.

TerrAscend Company Profile

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.